Home › Funds › Avidity Partners Management LP › IMUX

Avidity Partners Management LP position in IMUX

IMMUNIC INC · Health Care

Avidity Partners Management LP reported holding 669,941 shares of IMUX (IMMUNIC INC) in its Q2 2026 13F filing — a position valued at US$10.3M, representing 1.65% of its reported portfolio and ranking #11 among its reported holdings. Avidity Partners Management LP has disclosed IMUX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)669.94K sh
Reported value held$10.30M
Portfolio Weight1.65%
First reportedQ1 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Avidity Partners Management LP's IMUX position evolved

Avidity Partners Management LP first disclosed a stake in IMUX in Q1 2024 at 8,902,972 shares (US$11.8M). The position peaked in Q3 2024 at 8,266,000 shares, worth US$13.6M. Across 10 filings, Avidity Partners Management LP increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 669,941 shares valued at US$10.3M — a reduction of -6,029,470 shares quarter over quarter.. Notable position changes include a 44% trim in Q1 2025 (shares fell 36% over the following quarter), a 43% increase in Q1 2026 (shares rose 38% over the following quarter), a 90% trim in Q2 2026 (shares fell 39% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 8.90M $11.75M New
Q2 2024 8.90M $9.88M Hold
Q3 2024 8.27M $13.64M Reduce
Q4 2024 7.97M $7.97M Reduce
Q1 2025 4.45M $4.86M Reduce
Q2 2025 5.62M $3.92M Add
Q3 2025 4.70M $4.14M Reduce
Q4 2025 4.70M $2.51M Hold
Q1 2026 6.70M $7.44M Add
Q2 2026 669.94K $10.30M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMUX and 13F data

IMUX (IMMUNIC INC) is a Health Care company. 37 other funds we track also report a position in IMUX — the largest reported positions include BVF INC/IL (US$11.8M), Laurion Capital Management LP (US$9.4M), Jones Hill Capital LP (US$8.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMUX

All IMUX fund holders →

FAQ

How long has Avidity Partners Management LP held IMUX?

Avidity Partners Management LP has disclosed IMUX holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is Avidity Partners Management LP's current position in IMUX?

As of Q2 2026, Avidity Partners Management LP holds 669.94K shares of IMUX (IMMUNIC INC), valued at $10.30M, representing 1.65% of its reported portfolio and ranking #11.

Has Avidity Partners Management LP been buying or selling IMUX?

In the latest 13F filing (Q2 2026), Avidity Partners Management LP reduced its position in IMUX. The position peaked in Q3 2024 at 8.27M shares.

Which other funds hold IMUX?

Other major institutional holders of IMUX include BVF INC/IL, Laurion Capital Management LP, Jones Hill Capital LP, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.